These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 1697502

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
    Peters GJ, Laurensse E, Leyva A, Lankelma J, Pinedo HM.
    Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
    [Abstract] [Full Text] [Related]

  • 43. Enhancement by thymidine of 5-fluorouracil's inhibition of thymidylate synthetase in human tumors.
    Wolberg WH.
    Cancer Treat Rep; 1979 Jan; 63(11-12):1817-20. PubMed ID: 526916
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations.
    Grem JL, Chu E, Boarman D, Balis FM, Murphy RF, McAtee N, Allegra CJ.
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):36-44. PubMed ID: 1557656
    [Abstract] [Full Text] [Related]

  • 46. Serum factors attenuating the anti-tumor activity of 5-fluorouracil.
    Miwa M, Kojima T, Naruse T.
    Cancer Biother Radiopharm; 2001 Aug; 16(4):317-22. PubMed ID: 11603002
    [Abstract] [Full Text] [Related]

  • 47. [In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines--comparison between squamous cell carcinoma and adenocarcinoma].
    Ueda M, Misaki O, Yamada T, Okamoto Y, Goto M, Maeda T, Okamura S, Ueki M, Sugimoto O.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1423-30. PubMed ID: 2531191
    [Abstract] [Full Text] [Related]

  • 48. The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line.
    Johnston PG, Geoffrey F, Drake J, Voeller D, Grem JL, Allegra CJ.
    Eur J Cancer; 1996 Nov; 32A(12):2148-54. PubMed ID: 9014759
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Recombinant human interferon alpha-2a increases 5-fluorouracil efficacy by elevating fluorouridine concentration in tumor tissue.
    Kase S, Kubota T, Watanabe M, Teramoto T, Kitajima M, Hoffman RM.
    Anticancer Res; 1994 Nov; 14(3A):1155-9. PubMed ID: 8074466
    [Abstract] [Full Text] [Related]

  • 51. Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate.
    Sohn KJ, Smirnakis F, Moskovitz DN, Novakovic P, Yates Z, Lucock M, Croxford R, Kim YI.
    Gut; 2004 Dec; 53(12):1825-31. PubMed ID: 15542523
    [Abstract] [Full Text] [Related]

  • 52. Recent advances in the study of rTS proteins. rTS expression during growth and in response to thymidylate synthase inhibitors in human tumor cells.
    Dolnick BJ, Lu K, Yin MB, Rustum YM.
    Adv Enzyme Regul; 1997 Dec; 37():95-109. PubMed ID: 9381988
    [Abstract] [Full Text] [Related]

  • 53. Effects of 5-fluorouracil on human colon carcinoma and solid rat Walker 256 carcinosarcoma: evaluation as in vitro predictors of clinical response.
    Klubes P, Cerna I, Connelly K, Geelhoed GW, Mandel HG.
    Cancer Treat Rep; 1978 Jul; 62(7):1065-73. PubMed ID: 688247
    [Abstract] [Full Text] [Related]

  • 54. Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase.
    Murata S, Adachi M, Kioi M, Torigoe S, Ijichi K, Hasegawa Y, Ogawa T, Bhayani MK, Lai SY, Mitsudo K, Tohnai I.
    Anticancer Res; 2011 Sep; 31(9):2893-8. PubMed ID: 21868535
    [Abstract] [Full Text] [Related]

  • 55. Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.
    Wadler S, Wersto R, Weinberg V, Thompson D, Schwartz EL.
    Cancer Res; 1990 Sep 15; 50(18):5735-9. PubMed ID: 1697499
    [Abstract] [Full Text] [Related]

  • 56. Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats.
    Yoshisue K, Hironaga K, Yamaguchi S, Yamamoto A, Nagayama S, Kawaguchi Y.
    Cancer Chemother Pharmacol; 2000 Sep 15; 46(1):51-6. PubMed ID: 10912578
    [Abstract] [Full Text] [Related]

  • 57. Positive interaction between 5-FU and FdUMP[10] in the inhibition of human colorectal tumor cell proliferation.
    Liu J, Kolath J, Anderson J, Kolar C, Lawson TA, Talmadge J, Gmeiner WH.
    Antisense Nucleic Acid Drug Dev; 1999 Oct 15; 9(5):481-6. PubMed ID: 10555156
    [Abstract] [Full Text] [Related]

  • 58. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors.
    Van der Wilt CL, Pinedo HM, Smid K, Peters GJ.
    Cancer Res; 1992 Sep 15; 52(18):4922-8. PubMed ID: 1516048
    [Abstract] [Full Text] [Related]

  • 59. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
    Yang D, Qu J, Qu X, Cao Y, Xu L, Hou K, Feng W, Liu Y.
    Cancer Chemother Pharmacol; 2015 Sep 15; 76(3):575-86. PubMed ID: 26208739
    [Abstract] [Full Text] [Related]

  • 60. Biochemical modulation of 5-fluorouracil with a streptococcal preparation, OK-432, against murine colon-26 carcinoma.
    Funaki M, Gouchi A, Iwagaki H, Morimoto Y, Shimamura H, Ariki N, Tanaka N.
    Acta Med Okayama; 2000 Oct 15; 54(5):217-25. PubMed ID: 11061571
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.